封面
市場調查報告書
商品編碼
1886691

胰島素輸注幫浦市場-全球產業規模、佔有率、趨勢、機會和預測,按組件(泵體、輸注裝置和儲液器)、地區和競爭格局分類,2020-2030年預測

Insulin Infusion Pumps Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component (Pump Device, Infusion Set, and Reservoir), By Region and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球胰島素輸注幫浦市場規模為15.5億美元,預計到2030年將以6.50%的複合年成長率成長至22.6億美元。胰島素輸注幫浦是一種醫療器械,可提供持續的皮下胰島素輸注,為糖尿病患者提供了一種替代每日多次注射的治療方案。全球胰島素輸注幫浦市場的主要促進因素是全球糖尿病盛行率的不斷攀升,以及對能夠改善患者預後的先進便捷血糖管理解決方案日益成長的需求。

市場概覽
預測期 2026-2030
市場規模:2024年 15.5億美元
市場規模:2030年 22.6億美元
複合年成長率:2025-2030年 6.50%
成長最快的細分市場 泵浦裝置
最大的市場 北美洲

主要市場促進因素

全球胰島素輸注幫浦市場的擴張直接受到全球糖尿病診斷數量持續成長的影響。不斷擴大的患者群體從根本上拓寬了先進血糖管理解決方案的潛在市場。

主要市場挑戰

胰島素輸注幫浦的高昂成本,加上不同地區報銷政策的差異和限制,嚴重阻礙了其市場擴張。這些先進醫療設備所需的高額前期投入,對許多患者而言構成了相當大的經濟障礙,限制了他們獲得這種有益的糖尿病管理方案的機會。

主要市場趨勢

將人工智慧和機器學習應用於預測性胰島素給藥是一個關鍵趨勢,它提高了胰島素輸注系統的精確度和自主性。這些智慧演算法分析即時血糖資料、生活方式因素和歷史血糖模式,預測未來的血糖水平,並主動調整胰島素輸注量,從而預防低血糖和高血糖事件的發生。

目錄

第1章:產品概述

第2章:研究方法

第3章:執行概要

第4章:顧客之聲

第5章:全球胰島素輸注幫浦市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按組件(幫浦裝置、輸液器、儲液器)
    • 按地區
    • 按公司(2024 年)
  • 市場地圖

第6章:北美胰島素輸注幫浦市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲:國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章:歐洲胰島素輸注幫浦市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲:國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章:亞太地區胰島素輸注幫浦市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章:中東和非洲胰島素輸注幫浦市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲:國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章:南美洲胰島素輸注幫浦市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲:國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章:市場動態

  • 促進要素
  • 挑戰

第12章:市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章:全球胰島素輸注幫浦市場:SWOT分析

第14章:波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章:競爭格局

  • Medtronic plc
  • Insulet Corporation
  • Ascensia Diabetes Care Holdings AG
  • Tandem Diabetes Care, Inc.
  • Ypsomed Holding AG

第16章:策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 23537

The Global Insulin Infusion Pumps Market, valued at USD 1.55 Billion in 2024, is projected to experience a CAGR of 6.50% to reach USD 2.26 Billion by 2030. Insulin infusion pumps are medical devices providing continuous subcutaneous insulin delivery, offering an alternative to multiple daily injections for managing diabetes mellitus. The global market for these devices is primarily driven by the escalating prevalence of diabetes worldwide, coupled with the increasing demand for advanced and convenient glycemic management solutions that enhance patient outcomes.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.55 Billion
Market Size 2030USD 2.26 Billion
CAGR 2025-20306.50%
Fastest Growing SegmentPump Device
Largest MarketNorth America

Key Market Drivers

The global insulin infusion pumps market expansion is directly influenced by the persistent increase in worldwide diabetes diagnoses. This escalating patient demographic inherently broadens the addressable market for advanced glycemic management solutions. As more individuals are identified with diabetes, the demand for effective and less burdensome treatment modalities like insulin pumps intensifies, shifting away from conventional injection methods.

Key Market Challenges

The significant cost associated with insulin infusion pumps, coupled with varied and often limited reimbursement policies across different regions, presents a substantial impediment to market expansion. The high upfront investment required for these advanced medical devices creates a considerable financial barrier for many patients, restricting their access to this beneficial diabetes management option. This issue is particularly pronounced in developing economies, where healthcare infrastructure is less robust and patient affordability is a critical concern, leading to reduced adoption rates despite the clear clinical advantages.

Key Market Trends

The integration of Artificial Intelligence and Machine Learning for predictive dosing represents a pivotal trend, enhancing the precision and autonomy of insulin delivery systems. These intelligent algorithms analyze real-time glucose data, lifestyle factors, and historical patterns to forecast future glucose levels, proactively adjusting insulin delivery to prevent both hypoglycemic and hyperglycemic events.

Key Market Players

  • Medtronic plc
  • Insulet Corporation
  • Ascensia Diabetes Care Holdings AG
  • Tandem Diabetes Care, Inc.
  • Ypsomed Holding AG

Report Scope:

In this report, the Global Insulin Infusion Pumps Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Insulin Infusion Pumps Market, By Component:

  • Pump Device
  • Infusion Set
  • Reservoir

Insulin Infusion Pumps Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Insulin Infusion Pumps Market.

Available Customizations:

Global Insulin Infusion Pumps Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Insulin Infusion Pumps Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Component (Pump Device, Infusion Set, Reservoir)
    • 5.2.2. By Region
    • 5.2.3. By Company (2024)
  • 5.3. Market Map

6. North America Insulin Infusion Pumps Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component
    • 6.2.2. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Insulin Infusion Pumps Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Component
    • 6.3.2. Canada Insulin Infusion Pumps Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Component
    • 6.3.3. Mexico Insulin Infusion Pumps Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Component

7. Europe Insulin Infusion Pumps Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Insulin Infusion Pumps Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
    • 7.3.2. France Insulin Infusion Pumps Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
    • 7.3.3. United Kingdom Insulin Infusion Pumps Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
    • 7.3.4. Italy Insulin Infusion Pumps Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Component
    • 7.3.5. Spain Insulin Infusion Pumps Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Component

8. Asia Pacific Insulin Infusion Pumps Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Insulin Infusion Pumps Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
    • 8.3.2. India Insulin Infusion Pumps Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
    • 8.3.3. Japan Insulin Infusion Pumps Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
    • 8.3.4. South Korea Insulin Infusion Pumps Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
    • 8.3.5. Australia Insulin Infusion Pumps Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component

9. Middle East & Africa Insulin Infusion Pumps Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Insulin Infusion Pumps Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
    • 9.3.2. UAE Insulin Infusion Pumps Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
    • 9.3.3. South Africa Insulin Infusion Pumps Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component

10. South America Insulin Infusion Pumps Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Insulin Infusion Pumps Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
    • 10.3.2. Colombia Insulin Infusion Pumps Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
    • 10.3.3. Argentina Insulin Infusion Pumps Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Insulin Infusion Pumps Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Medtronic plc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Insulet Corporation
  • 15.3. Ascensia Diabetes Care Holdings AG
  • 15.4. Tandem Diabetes Care, Inc.
  • 15.5. Ypsomed Holding AG

16. Strategic Recommendations

17. About Us & Disclaimer